Zahra Gholizadeh

Zahra Gholizadeh

Zahra Gholizadeh

Zahra Gholizadeh

Introduction

Publications

10Publications

223Reads

-Profile Views

Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer.

Eur J Cancer 2020 Apr 4;129:80-96. Epub 2020 Mar 4.

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.01.010DOI Listing
April 2020

A Case-Control Study on the p73 G4A Gene Polymorphism and Susceptibility to Breast Cancer in an Iranian Population.

Iran J Public Health 2019 Oct;48(10):1855-1860

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908912PMC
October 2019

A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice.

J Drug Target 2018 04 18;26(4):365-372. Epub 2017 Oct 18.

c Nanotechnology Research Center , Mashhad University of Medical Sciences , Mashhad , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1061186X.2017.1387788DOI Listing
April 2018

Targeting the leptin receptor: To evaluate therapeutic efficacy and anti-tumor effects of Doxil, in vitro and in vivo in mice bearing C26 colon carcinoma tumor.

Colloids Surf B Biointerfaces 2018 Apr 31;164:107-115. Epub 2018 Jan 31.

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2018.01.035DOI Listing
April 2018

Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.

J Cell Mol Med 2018 01 25;22(1):558-567. Epub 2017 Sep 25.

Biotechnology Research Center, Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.13343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742681PMC
January 2018

Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer.

Immunol Lett 2017 10 21;190:108-117. Epub 2017 Jul 21.

Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2017.07.009DOI Listing
October 2017

Quality evaluation of Persian nutrition and diet therapy websites.

J Educ Health Promot 2017 5;6:48. Epub 2017 Jun 5.

Department of Biostatistics and Epidemiology, Faculty of Health, Isfahan University of Medical Sciences, Isfahan, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jehp.jehp_83_14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470293PMC
June 2017

Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model.

Int J Pharm 2015 Nov 21;495(1):162-170. Epub 2015 Aug 21.

Biotechnology Research Center, Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 91775-1365, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2015.08.048DOI Listing
November 2015